E

Envista Holdings Corp
NYSE:NVST

Watchlist Manager
Envista Holdings Corp
NYSE:NVST
Watchlist
Price: 19.2691 USD 1.68%
Market Cap: 3.3B USD
Have any thoughts about
Envista Holdings Corp?
Write Note

Envista Holdings Corp
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Envista Holdings Corp
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
E
Envista Holdings Corp
NYSE:NVST
Total Receivables
$407.5m
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Receivables
$3B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Total Receivables
$2.5B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Total Receivables
$3.7B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Total Receivables
$7.1B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Receivables
$1.2B
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
16%
No Stocks Found

Envista Holdings Corp
Glance View

Market Cap
3.3B USD
Industry
Health Care

Envista Holdings Corp., a prominent player in the dental industry, spins a captivating narrative of innovation and expertise. Emerging from a legacy rooted in the exceptional engineering standards of Danaher Corporation, Envista was formed to focus sharply on dental products and solutions. Its operational structure is divided into three main segments: Specialty Products & Technologies, Orthodontic Products, and Equipment & Consumables. With a strategic emphasis on orthodontics and endodontics, the company engineers advanced technological solutions such as clear aligners, imaging software, and digital treatment planning tools. This specialization is key to its operations, allowing Envista to cater to dental practitioners' diverse needs with products that boost the efficiency and precision of dental treatments. Revenue generation for Envista hinges upon its broad portfolio of trusted brands, including KaVo Kerr, Nobel Biocare, and Ormco, which are synonymous with quality in the dental field. Through these brands, Envista not only manufactures and sells premium dental equipment and supplies, but also provides comprehensive services from maintenance and repair to educational support. The company utilizes a robust distribution network and partners with dental service organizations globally, ensuring its products reach a wide audience. Furthermore, Envista’s commitment to research and development fuels its profitability by continually offering state-of-the-art solutions that meet the evolving demands of the dental industry. This relentless focus on innovation and customer-centric approaches underpin its financial performance, positioning Envista as a formidable force in its market.

NVST Intrinsic Value
25.3399 USD
Undervaluation 24%
Intrinsic Value
Price
E

See Also

What is Envista Holdings Corp's Total Receivables?
Total Receivables
407.5m USD

Based on the financial report for Dec 31, 2023, Envista Holdings Corp's Total Receivables amounts to 407.5m USD.

What is Envista Holdings Corp's Total Receivables growth rate?
Total Receivables CAGR 5Y
-2%

Over the last year, the Total Receivables growth was 4%. The average annual Total Receivables growth rates for Envista Holdings Corp have been 4% over the past three years , -2% over the past five years .

Back to Top